Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Companion biomarkers: paving the pathway to personalized treatment for cancer.

Clinical chemistry - 1 Oct 2013

Duffy Michael J, Crown John

Abstract excerpt

BACKGROUND: Companion biomarkers are biomarkers that are used in combination with specific therapies and that prospectively help predict likely response or severe toxicity. In this article we review the role of companion biomarkers in guiding treatment in patients with cancer. CONTENT: In addition to the established companion biomarkers such as estrogen receptors and HER2 (human epidermal growth factor receptor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Aromatase Inhibitors
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to ras Proteins

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Translocation, Genetic

Source

Identifiers

PMID: 23656699
DOI: 10.1373/clinchem.2012.200477

Genes

BRAF
ALK
EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Companion biomarkers: paving the pathway to personalized treatment for cancer.PMID 23656699Read ↗

Use of molecular markers for predicting therapy response in cancer patients.Semantic proximity Read ↗

Companion diagnostic testing for targeted cancer therapies: an overview.Semantic proximity Read ↗

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.Semantic proximity Read ↗

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.Semantic proximity Read ↗

Established and Potential Predictive Biomarkers in Gastrointestinal Cancer--c-Kit, Her2, Ras and Beyond.Semantic proximity Read ↗

Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials.Semantic proximity Read ↗

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity Read ↗

Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.Semantic proximity Read ↗

EGFR Signaling in Colorectal Cancer: Novel Therapeutic Strategies, Predictive Biomarkers, and Counteracting Treatment Resistance.Semantic proximity Read ↗

Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.